E
BioLineRx Ltd. BLRX
$2.52 -$0.13-4.91%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 77.05% 63.66% 102.61% 94.28% -142.26%
Total Depreciation and Amortization 174.96% 280.09% 140.40% 246.33% 245.99%
Total Amortization of Deferred Charges 1,157.63% -- -- -- --
Total Other Non-Cash Items -317.56% -129.77% -152.90% -197.95% 347.00%
Change in Net Operating Assets -102.79% -394.01% -659.92% -4,045.05% 1,064.37%
Cash from Operations -272.51% 0.77% -17.01% -76.01% 187.82%
Capital Expenditure 137.50% 100.00% 59.70% 0.00% 71.93%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 154.72% 148.29% -177.17% 150.51% -620.01%
Cash from Investing 154.70% 148.35% -177.88% 151.23% -628.09%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -1,302.43% -10.19% -578.36% -1,724.49% -818.09%
Issuance of Common Stock -12.77% -- -- -- 420,000.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -109.45% -134.81% 17,920.15% -1,724.49% 1,914.53%
Foreign Exchange rate Adjustments -15.63% 212.50% -10.57% 152.04% 484.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 146.08% 66.89% 250.00% 214.07% -37.89%
Weiss Ratings